BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 26772969)

  • 1. Aβ-mediated spine changes in the hippocampus are microtubule-dependent and can be reversed by a subnanomolar concentration of the microtubule-stabilizing agent epothilone D.
    Penazzi L; Tackenberg C; Ghori A; Golovyashkina N; Niewidok B; Selle K; Ballatore C; Smith AB; Bakota L; Brandt R
    Neuropharmacology; 2016 Jun; 105():84-95. PubMed ID: 26772969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Region-specific dendritic simplification induced by Aβ, mediated by tau via dysregulation of microtubule dynamics: a mechanistic distinct event from other neurodegenerative processes.
    Golovyashkina N; Penazzi L; Ballatore C; Smith AB; Bakota L; Brandt R
    Mol Neurodegener; 2015 Nov; 10():60. PubMed ID: 26541821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraneuronal APP and extracellular Aβ independently cause dendritic spine pathology in transgenic mouse models of Alzheimer's disease.
    Zou C; Montagna E; Shi Y; Peters F; Blazquez-Llorca L; Shi S; Filser S; Dorostkar MM; Herms J
    Acta Neuropathol; 2015 Jun; 129(6):909-20. PubMed ID: 25862638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal Store-Operated Calcium Entry and Mushroom Spine Loss in Amyloid Precursor Protein Knock-In Mouse Model of Alzheimer's Disease.
    Zhang H; Wu L; Pchitskaya E; Zakharova O; Saito T; Saido T; Bezprozvanny I
    J Neurosci; 2015 Sep; 35(39):13275-86. PubMed ID: 26424877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing microtubule stabilization rescues cognitive deficits and ameliorates pathological phenotype in an amyloidogenic Alzheimer's disease model.
    Fernandez-Valenzuela JJ; Sanchez-Varo R; Muñoz-Castro C; De Castro V; Sanchez-Mejias E; Navarro V; Jimenez S; Nuñez-Diaz C; Gomez-Arboledas A; Moreno-Gonzalez I; Vizuete M; Davila JC; Vitorica J; Gutierrez A
    Sci Rep; 2020 Sep; 10(1):14776. PubMed ID: 32901091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the Motor Protein Eg5/Kinesin-5 in Amyloid β-Mediated Impairment of Hippocampal Long-Term Potentiation and Dendritic Spine Loss.
    Freund RK; Gibson ES; Potter H; Dell'Acqua ML
    Mol Pharmacol; 2016 May; 89(5):552-9. PubMed ID: 26957206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EphA4 loss improves social memory performance and alters dendritic spine morphology without changes in amyloid pathology in a mouse model of Alzheimer's disease.
    Poppe L; Rué L; Timmers M; Lenaerts A; Storm A; Callaerts-Vegh Z; Courtand G; de Boer A; Smolders S; Van Damme P; Van Den Bosch L; D'Hooge R; De Strooper B; Robberecht W; Lemmens R
    Alzheimers Res Ther; 2019 Dec; 11(1):102. PubMed ID: 31831046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid beta: a putative intra-spinal microtubule-depolymerizer to induce synapse-loss or dentritic spine shortening in Alzheimer's disease.
    Mitsuyama F; Futatsugi Y; Okuya M; Karagiozov K; Peev N; Kato Y; Kanno T; Sano H; Koide T
    Ital J Anat Embryol; 2009; 114(2-3):109-20. PubMed ID: 20198823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Activation of Experience-Independent Dendritic Spine Turnover in a Mouse Model of Alzheimer's Disease.
    Heiss JK; Barrett J; Yu Z; Haas LT; Kostylev MA; Strittmatter SM
    Cereb Cortex; 2017 Jul; 27(7):3660-3674. PubMed ID: 27365298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for altered dendritic spine compartmentalization in Alzheimer's disease and functional effects in a mouse model.
    Androuin A; Potier B; Nägerl UV; Cattaert D; Danglot L; Thierry M; Youssef I; Triller A; Duyckaerts C; El Hachimi KH; Dutar P; Delatour B; Marty S
    Acta Neuropathol; 2018 Jun; 135(6):839-854. PubMed ID: 29696365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pridopidine stabilizes mushroom spines in mouse models of Alzheimer's disease by acting on the sigma-1 receptor.
    Ryskamp D; Wu L; Wu J; Kim D; Rammes G; Geva M; Hayden M; Bezprozvanny I
    Neurobiol Dis; 2019 Apr; 124():489-504. PubMed ID: 30594810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoxetine Protects against Dendritic Spine Loss in Middle-aged APPswe/PSEN1dE9 Double Transgenic Alzheimer's Disease Mice.
    Ma J; Gao Y; Tang W; Huang W; Tang Y
    Curr Alzheimer Res; 2020; 17(1):93-103. PubMed ID: 32053075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gamma-secretase inhibition reduces spine density in vivo via an amyloid precursor protein-dependent pathway.
    Bittner T; Fuhrmann M; Burgold S; Jung CK; Volbracht C; Steiner H; Mitteregger G; Kretzschmar HA; Haass C; Herms J
    J Neurosci; 2009 Aug; 29(33):10405-9. PubMed ID: 19692615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
    Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
    Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effects of amyloid-beta and wild-type human tau on dendritic spine loss in a floxed double transgenic model of Alzheimer's disease.
    Chabrier MA; Cheng D; Castello NA; Green KN; LaFerla FM
    Neurobiol Dis; 2014 Apr; 64():107-17. PubMed ID: 24440055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Store-Operated Calcium Channel Complex in Postsynaptic Spines: A New Therapeutic Target for Alzheimer's Disease Treatment.
    Zhang H; Sun S; Wu L; Pchitskaya E; Zakharova O; Fon Tacer K; Bezprozvanny I
    J Neurosci; 2016 Nov; 36(47):11837-11850. PubMed ID: 27881772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid-beta induced retrograde axonal degeneration in a mouse tauopathy model.
    Nishioka C; Liang HF; Barsamian B; Sun SW
    Neuroimage; 2019 Apr; 189():180-191. PubMed ID: 30630081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergent pathways mediate spine alterations and cell death induced by amyloid-beta, wild-type tau, and R406W tau.
    Tackenberg C; Brandt R
    J Neurosci; 2009 Nov; 29(46):14439-50. PubMed ID: 19923278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RanBP9 overexpression accelerates loss of dendritic spines in a mouse model of Alzheimer's disease.
    Wang R; Palavicini JP; Wang H; Maiti P; Bianchi E; Xu S; Lloyd BN; Dawson-Scully K; Kang DE; Lakshmana MK
    Neurobiol Dis; 2014 Sep; 69():169-79. PubMed ID: 24892886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid precursor protein (APP) regulates synaptic structure and function.
    Tyan SH; Shih AY; Walsh JJ; Maruyama H; Sarsoza F; Ku L; Eggert S; Hof PR; Koo EH; Dickstein DL
    Mol Cell Neurosci; 2012 Aug; 51(1-2):43-52. PubMed ID: 22884903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.